HeyJaredChristy Santhosh
- Indexed articles, last 90 days
- 3
- Latest publication
- Sep 22, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 8, 2026
Latest articles
Amgen's Autoimmune Drug Succeeds in Late-stage Trial (opens the original)
Read excerpt
Sept 22 (Reuters) - Amgen said on Tuesday its experimental drug to treat an autoimmune disease that attacks the body's moisture-producing glands met the main goal of reducing disease activity in a late-stage trial, sending its shares up 4% in morning trading. • The drug dazodalibep showed statistically significant and clinically meaningful improvement in patients with Sjogren's disease who had moderate-to-severe disease activity at week 48. • Sjogren's disease can cause extensive dryness of
AstraZeneca's Breast Cancer Pill Fails in Late-stage Trial (opens the original)
Read excerpt
Sept 11 (Reuters) - AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company said on Friday, a week after the treatment received U.S. approval. U.S.-listed shares of AstraZeneca fell 3% in aftermarket trading. The drug camizestrant, sold as Etcamah, when tested in combination with Pfizer's cancer drug Ibrance, showed only a numerical, but not statistically significant, improvement in progression-free survival in p
Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success (opens the original)
Read excerpt
July 7 (Reuters) - Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates of nausea and vomiting among participants in a late-stage trial in China, overshadowing the experimental treatment's success in meeting the study's main goal. The drug, HRS-7535, was being tested in patients with obesity and diabetes in two separate trials conducted by Kailera's China-based partner Jiangsu Hengrui Pharmaceutical. U.S. drugmakers have been increasingly look
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.